Get started
Author

Naoki Hiramatsu

Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice
2016 · Satoshi Tanaka, Hayato Hikita, et al. · Hepatology · 391
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
1994 · Naoki Hiramatsu, Norio Hayashi, et al. · Hepatology · 357
PDF
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
2015 · K. Ashida, Y. Sakurai, et al. · Alimentary Pharmacology & Therapeutics · 308
PDF
Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection
2004 · Masahisa Jinushi, Tetsuo Takehara, et al. · The Journal of Immunology · 234
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas
2005 · Masahisa Jinushi, Tetsuo Takehara, et al. · Journal of Hepatology · 226
Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection
2004 · Tatsuya Kanto, Michiyo Inoue, et al. · The Journal of Infectious Diseases · 223
Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
2015 · K. Ashida, Y. Sakurai, et al. · Alimentary Pharmacology & Therapeutics · 195
PDF
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
1995 · Akinori Kasahara, Norio Hayashi, et al. · Hepatology · 158
PDF
Fas antigen expression in liver tissues of patients with chronic hepatitis B
1996 · Kiyoshi Mochizuki, Norio Hayashi, et al. · Journal of Hepatology · 145
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis
2012 · Tokuhiro Matsubara, Tatsuya Kanto, et al. · Hepatology · 144
Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003
2008 · Hideo Tanaka, Yasuharu Imai, et al. · Annals of Internal Medicine · 129
Immunohistochemical Detection of Hepatitis C Virus-Infected Hepatocytes in Chronic Liver Disease With Monoclonal Antibodies to Core, Envelope and Ns3 Regions of the Hepatitis C Virus Genome
1992 · Naoki Hiramatsu, Norio Hayashi, et al. · Hepatology · 119
Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy
2013 · Tsugiko Oze, Naoki Hiramatsu, et al. · Clinical Gastroenterology and Hepatology · 110
PDF
Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus
2012 · Sachiyo Yoshio, Tatsuya Kanto, et al. · Hepatology · 110
PDF
Liver-Directed Gene Transfer in Non-Human Primates
1997 · Deborah E. Sullivan, Srikanta Dash, et al. · Human Gene Therapy · 109
JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2
2016 · Yasuhiro Asahina, Namiki Izumi, et al. · Hepatology Research · 91
Glycomic Analysis of Alpha-Fetoprotein L3 in Hepatoma Cell Lines and Hepatocellular Carcinoma Patients
2008 · Takatoshi Nakagawa, Eiji Miyoshi, et al. · Journal of Proteome Research · 87
Anticancer Chemotherapy Inhibits MHC Class I–Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
2009 · Keisuke Kohga, Tetsuo Takehara, et al. · Cancer Research · 84
Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell‐mediated induction of CD4+ CD25+ T cells with PD‐1‐dependent regulatory activities
2006 · Masahisa Jinushi, Tetsuo Takehara, et al. · Immunology · 82
Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon‐based antiviral therapy
2014 · Naoki Hiramatsu, Tsugiko Oze, et al. · Hepatology Research · 81
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
2013 · Yoshihiro Kamada, Maaya Akita, et al. · PLoS ONE · 76
PDF
Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver
2004 · Takuya Miyagi, Tetsuo Takehara, et al. · Hepatology · 76
PDF
Serum levels of soluble major histocompatibility complex (MHC) class I‐related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
2008 · Keisuke Kohga, Tetsuo Takehara, et al. · Cancer Science · 70
Ribavirin dose reduction raises relapse rate dose‐dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha‐2b plus ribavirin
2009 · N. Hiramatsu, T. Oze, et al. · Journal of Viral Hepatitis · 68
A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis
2017 · Katsuhiko Iwakiri, Yuuichi Sakurai, et al. · Therapeutic Advances in Gastroenterology · 67
PDF
Works count: 197
Citation count: 6,456
H-index: 42
I10-index: 116
Year
Topic
Type